Economic and Quality of Life Benefits of Anti-VEGF Therapy

Author:

Hodgson Nickisa1,Wu Frances1,Zhu Jie12,Wang Wenqui13,Ferreyra Henry1,Zhang Kang14,Wang Jiawei5

Affiliation:

1. Shiley Eye Institute and Biomaterials and Tissue Engineering Center, Department of Ophthalmology and Institute for Engineering in Medicine, University of California, San Diego, La Jolla, California 92093, United States

2. Department of Ophthalmology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China

3. Department of Ophthalmology, Shanghai First People’s Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai 20080, China

4. Veterans Administration Healthcare System, San Diego, California 92093, United States

5. Zhongshan Opthalmic Center, Sun Yat-sen University, Guangzhou 510060, China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference43 articles.

1. Wittenborn, J. S. and Rein, D. B.Cost of vision problems: the economic burden of vision loss and eye disorders in the United States.NORC at the University of Chicago. Prepared for Prevent Blindness America,Chicago, IL, 2013.

2. Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study

3. The Economic Burden of Major Adult Visual Disorders in the United States

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3